Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine for Kienböck disease
IRCT2017073035382N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of deferoxamine in Kienböck disease, sponsored by Iran University of Medical Sciences. Started Dec 2017; status: completed.
02
Drugs
deferoxamine
03
Conditions
Kienböck disease
Beyond the preview
Go deeper on IRCT2017073035382N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017073035382N1.